Pivotal studies by Lin et al. (49) found that a subpopulation of CD14+/HLA-DR−/low monocytes exert immunosuppressive function in NHL patients by depleting arginine bioavailability through Arg-1 activity. The gene discussed is ARG1; the disease is non-Hodgkin lymphoma.